Rik C. Schoemaker

7.9k total citations
198 papers, 6.2k citations indexed

About

Rik C. Schoemaker is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Psychiatry and Mental health. According to data from OpenAlex, Rik C. Schoemaker has authored 198 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pharmacology, 30 papers in Cardiology and Cardiovascular Medicine and 26 papers in Psychiatry and Mental health. Recurrent topics in Rik C. Schoemaker's work include Epilepsy research and treatment (20 papers), Antibiotics Pharmacokinetics and Efficacy (18 papers) and Pharmacological Effects and Toxicity Studies (17 papers). Rik C. Schoemaker is often cited by papers focused on Epilepsy research and treatment (20 papers), Antibiotics Pharmacokinetics and Efficacy (18 papers) and Pharmacological Effects and Toxicity Studies (17 papers). Rik C. Schoemaker collaborates with scholars based in Netherlands, United States and Belgium. Rik C. Schoemaker's co-authors include Adam F. Cohen, Jacobus Burggraaf, Joop van Gerven, Eef G.W.M. Lentjes, D. D. Breimer, Jan den Hartigh, Fred P.H.T.M. Romijn, Olga Weijtens, Monique S. M. Pieters and AF Cohen and has published in prestigious journals such as Circulation, Blood and Annals of Internal Medicine.

In The Last Decade

Rik C. Schoemaker

193 papers receiving 6.0k citations

Peers

Countries citing papers authored by Rik C. Schoemaker

Since Specialization

Citations

This map shows the geographic impact of Rik C. Schoemaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rik C. Schoemaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rik C. Schoemaker more than expected).

Fields of papers citing papers by Rik C. Schoemaker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rik C. Schoemaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rik C. Schoemaker. The network helps show where Rik C. Schoemaker may publish in the future.

Co-authorship network of co-authors of Rik C. Schoemaker

This figure shows the co-authorship network connecting the top 25 collaborators of Rik C. Schoemaker. A scholar is included among the top collaborators of Rik C. Schoemaker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rik C. Schoemaker. Rik C. Schoemaker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Model‐based comparisons of post‐treatment free IgE and FEV1 between omalizumab asthma dosing tables in the United States and European Union 2024 ·British Journal of Clinical Pharmacology ·Rui Zhu, Rik C. Schoemaker, (unknown), Xianbin Tian, (unknown), Theodore A. Omachi, Amita Joshi, Jin Y. Jin, Ryan Owen	1
2	Pharmacokinetics and exposure-efficacy relationships of omalizumab in patients with nasal polyps 2021 ·Pulmonary Pharmacology & Therapeutics ·Rui Zhu, Ryan Owen, Justin Wilkins, Rik C. Schoemaker, Xianbin Tian, (unknown), (unknown), Shweta Vadhavkar, Melissa Cheu, Kit Wong, Theodore A. Omachi, Wendy S. Putnam, Angelica Quartino	2
3	Population pharmacokinetics and covariate analysis of Sym004, an antibody mixture against the epidermal growth factor receptor, in subjects with metastatic colorectal cancer and other solid tumors 2019 ·Journal of Pharmacokinetics and Pharmacodynamics ·(unknown), Rik C. Schoemaker, (unknown), (unknown), Clara Montagut, Scott Kopetz, Josep Tabernero, Michael Kragh, Janet R. Wade	3
4	Modeling and simulation for the evaluation of dose adaptation rules of intravenous lacosamide in children 2018 ·Epilepsy Research ·Julia Winkler, Rik C. Schoemaker, Armel Stockis	5
5	Evaluation of brivaracetam efficacy as monotherapy in adult patients with focal seizures 2017 ·Epilepsy Research ·Rik C. Schoemaker, Janet R. Wade, Joseph D’Souza, Armel Stockis	12
6	Orexin Receptor Antagonism, a New Sleep-Promoting Paradigm: An Ascending Single-Dose Study With Almorexant 2010 ·Clinical Pharmacology & Therapeutics ·Petra Hoever, (unknown), Julia Winkler, Rik C. Schoemaker, Eleonora Chiossi, JMA van Gerven, Jasper Dingemanse	85
7	A comparative study of two methods for attaining constant alcohol levels 2008 ·British Journal of Clinical Pharmacology ·(unknown), Joop van Gerven, Glenn Dumont, S. Paltansing, (unknown), (unknown), Albert Dahan, Adam F. Cohen, Rik C. Schoemaker	23
8	Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat 2006 ·PubMed ·David G. Levitt, Rik C. Schoemaker	41
9	Effect of garlic powder on C-reactive protein and plasma lipids in overweight and smoking subjects 2006 ·American Journal of Clinical Nutrition ·Martijn B. A. van Doorn, (unknown), Piet Meijer, Ingrid M. C. Kamerling, Rik C. Schoemaker, Verena M. Dirsch, Angelika M. Vollmar, Thomas Haffner, Rolf Gebhardt, Adam F. Cohen, P. Hans, Jacobus Burggraaf	52
10	Withdrawing chronic quinapril treatment causes rebound volume overload and endothelial dysfunction in rats with myocardial infarction 2004 ·Data Archiving and Networked Services (DANS) ·Bart Westendorp, Rik C. Schoemaker, Hendrik Buikema, Wiek H. van Gilst	0
11	Hydrochlorothiazide increases tissue concentrations of the ACE inhibitor zofenoprilat in rats with myocardial infarction 2004 ·Data Archiving and Networked Services (DANS) ·Bart Westendorp, Hendrik Buikema, Rik C. Schoemaker, (unknown), Wiek H. van Gilst	0
12	Pharmacokinetics of rectal tramadol in postoperative paediatric patients 2004 ·British Journal of Anaesthesia ·J. Zwaveling, (unknown), (unknown), Rik C. Schoemaker, (unknown), Pieter Vermeij, Jacobus Burggraaf	25
13	No Influence of Acute Hypertriglyceridemia on Plasma t-PA in Healthy Male Volunteers 2001 ·Thrombosis Research ·Michiel J. B. Kemme, Jacobus Burggraaf, Rik C. Schoemaker, (unknown)	3
14	Continuous intravenous furosemide in haemodynamically unstable children after cardiac surgery 2001 ·Intensive Care Medicine ·(unknown), (unknown), Joana E. Kist‐van Holthe, Jan den Hartigh, Rik C. Schoemaker, Adam F. Cohen, J. Burggraaf	38
15	The influence of cisapride and clarithromycin on QT intervals in healthy volunteers 1998 ·Clinical Pharmacology & Therapeutics ·Aernout D. van Haarst, (unknown), Joop van Gerven, Rik C. Schoemaker, Joop C. van Oene, (unknown), M C Coene, Adam F. Cohen	125
16	Place de l'amisulpride dans la classe des neuroleptiques atypiques 1996 ·Ghislaine Perrault, Rik C. Schoemaker, B. Scatton	2
17	Effects of increased liver blood flow on the kinetics and dynamics of recombinant tissue-type plasminogen activator* 1996 ·Clinical Pharmacology & Therapeutics ·(unknown), L.G.M. Huisman, (unknown), G. Dooijewaard, (unknown), Rik C. Schoemaker, (unknown), Adam F. Cohen	12
18	Life table analysis of fecundity in intravenously gonadotropin-releasing hormone-treated patients with normogonadotropic and hypogonadotropic amenorrhea 1991 ·Fertility and Sterility ·D.D.M. Braat, Rik C. Schoemaker, J. Schoemaker	17
19	LUTEINIZING HORMONE AND FOLLICLE STIMULATING HORMONE SECRETION PATTERNS IN GIRLS THROUGHOUT PUBERTY MEASURED USING HIGHLY SENSITIVE IMMUNORADIOMETRIC ASSAYS 1990 ·Clinical Endocrinology ·J M B Wennink, (unknown), Rik C. Schoemaker, (unknown), J. Schoemaker	40
20	Coincidence of behavioural state parameters in the human fetus at three gestational ages 1990 ·Early Human Development ·J.M. Swartjes, Herman P. van Geijn, R. Mantel, E.E. van Woerden, Rik C. Schoemaker	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact